• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性透析治疗下的终末期肾病患者肾功能的持续恢复:系统评价和荟萃分析。

Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis.

机构信息

Unit of Nephrology, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

出版信息

Nutrients. 2023 Mar 25;15(7):1595. doi: 10.3390/nu15071595.

DOI:10.3390/nu15071595
PMID:37049436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10096619/
Abstract

The prevalence of recovery of kidney function (RKF) in patients under maintenance dialysis is poorly defined mainly because of different definitions of RKF. Therefore, to gain more insights into the epidemiology of RKF, we performed a systematic review and meta-analysis of studies addressing the prevalence of sustained (at least for 30 days) RKF in patients under maintenance dialysis. Acute kidney injury (AKI) and RKF in the first 90 days of dialysis were the main exclusion criteria. Overall, 7 studies (10 cohorts) including 2,444,943 chronic dialysis patients (range: 430-1,900,595 patients) were meta-analyzed. The period of observation ranged from 4 to 43 years. The prevalence of RKF was 1.49% (95% C.I.:1.05-2.11; < 0.001] with high heterogeneity I2: 99.8%, < 0.001. The weighted mean dialysis vintage before RKF was 294 ± 165 days; RKF persisted for a weighted mean of 27.5 months. The percentage of RKF was higher in studies from the U.S. (1.96% [95% C.I.: 1.24-3.07]) as compared to other countries (1.04% [95%C.I.: 0.66-1.62]; = 0.049). In conclusion, sustained RKF unrelated to AKI occurs in about 1.5% of patients under maintenance dialysis. On average, RKF patients discontinue chronic dialysis about ten months after starting treatment and live free of dialysis for more than two years. The higher prevalence of RKF reported in the U.S. versus other countries suggests a major role of country-specific policies for dialysis start.

摘要

维持性透析患者肾功能恢复(RKF)的流行率定义不明确,主要是因为 RKF 的定义不同。因此,为了更深入地了解 RKF 的流行病学,我们对探讨维持性透析患者持续(至少 30 天)RKF 流行率的研究进行了系统评价和荟萃分析。急性肾损伤(AKI)和透析前 90 天的 RKF 是主要排除标准。共有 7 项研究(10 项队列研究)纳入了 2444943 例慢性透析患者(范围:430-1900595 例)进行荟萃分析。观察期为 4 至 43 年。RKF 的流行率为 1.49%(95%CI:1.05-2.11; < 0.001],存在高度异质性 I2:99.8%, < 0.001。发生 RKF 前的加权平均透析龄为 294 ± 165 天;RKF 持续的加权平均时间为 27.5 个月。来自美国的研究中 RKF 的比例较高(1.96%[95%CI:1.24-3.07]),而其他国家的比例较低(1.04%[95%CI:0.66-1.62]; = 0.049)。总之,与 AKI 无关的持续性 RKF 发生在约 1.5%的维持性透析患者中。平均而言,RKF 患者在开始治疗后约十个月停止慢性透析,并在两年多的时间内无需透析。与其他国家相比,美国报告的 RKF 发生率较高,表明透析开始的国家特定政策发挥了重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/f615101557b2/nutrients-15-01595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/3dde45b599a4/nutrients-15-01595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/f43f7c07b08f/nutrients-15-01595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/293389bc3a41/nutrients-15-01595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/f615101557b2/nutrients-15-01595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/3dde45b599a4/nutrients-15-01595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/f43f7c07b08f/nutrients-15-01595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/293389bc3a41/nutrients-15-01595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78e/10096619/f615101557b2/nutrients-15-01595-g004.jpg

相似文献

1
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis.慢性透析治疗下的终末期肾病患者肾功能的持续恢复:系统评价和荟萃分析。
Nutrients. 2023 Mar 25;15(7):1595. doi: 10.3390/nu15071595.
2
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
3
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
4
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾脏病患者的HMG辅酶A还原酶抑制剂(他汀类药物)
Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.终末期肾病透析患者中重组人促红细胞生成素治疗贫血的给药频率
Cochrane Database Syst Rev. 2002(4):CD003895. doi: 10.1002/14651858.CD003895.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Intensity of continuous renal replacement therapy for acute kidney injury.急性肾损伤的持续肾脏替代治疗强度
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD010613. doi: 10.1002/14651858.CD010613.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
How Does Contrast Administration Influence Creatinine Dynamics in Trauma Patients With Acute Kidney Injury?造影剂的使用如何影响急性肾损伤创伤患者的肌酐动态变化?
Cureus. 2025 May 9;17(5):e83788. doi: 10.7759/cureus.83788. eCollection 2025 May.
2
Membranous nephropathy: pathogenesis and treatments.膜性肾病:发病机制与治疗
MedComm (2020). 2024 Jun 29;5(7):e614. doi: 10.1002/mco2.614. eCollection 2024 Jul.

本文引用的文献

1
Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists.影响开始透析决策的因素:一项对美国肾脏病医生的全国性调查。
Am J Nephrol. 2022;53(10):722-729. doi: 10.1159/000528167. Epub 2022 Dec 7.
2
Predictors of kidney function recovery among incident ESRD patients.预测新发生终末期肾病患者肾功能恢复的因素。
BMC Nephrol. 2021 Apr 21;22(1):142. doi: 10.1186/s12882-021-02345-7.
3
Recovery of kidney function after dialysis initiation in children and adults in the US: A retrospective study of United States Renal Data System data.
美国儿童和成人透析起始后肾功能的恢复:对美国肾脏数据系统数据的回顾性研究。
PLoS Med. 2021 Feb 19;18(2):e1003546. doi: 10.1371/journal.pmed.1003546. eCollection 2021 Feb.
4
Recovery of kidney function in patients treated with maintenance dialysis-a report from the ERA-EDTA Registry.维持性透析治疗患者的肾功能恢复:来自 ERA-EDTA 登记处的报告。
Nephrol Dial Transplant. 2021 May 27;36(6):1078-1087. doi: 10.1093/ndt/gfaa368.
5
Potential Impact of Medicare Payment Policy on Misclassification of Dialysis-Requiring Acute Kidney Injury as ESRD: A National Temporal Trend Analysis.医疗保险支付政策对将需要透析的急性肾损伤误诊为终末期肾病的潜在影响:一项全国性时间趋势分析
Am J Kidney Dis. 2018 Aug;72(2):311-313. doi: 10.1053/j.ajkd.2018.01.054. Epub 2018 Apr 1.
6
Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.长期使用依库珠单抗治疗有助于非典型溶血性尿毒症综合征所致终末期肾病的恢复。
Intern Med. 2017;56(9):1085-1088. doi: 10.2169/internalmedicine.56.7862. Epub 2017 May 1.
7
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.急性肾损伤与肾脏恢复:急性疾病质量倡议(ADQI)16 工作组的共识报告。
Nat Rev Nephrol. 2017 Apr;13(4):241-257. doi: 10.1038/nrneph.2017.2. Epub 2017 Feb 27.
8
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险:一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
9
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question.肾脏病学护理下的5期慢性肾脏病:透析与否,这是个问题。
J Nephrol. 2016 Apr;29(2):153-161. doi: 10.1007/s40620-015-0243-8. Epub 2015 Nov 19.
10
Epidemiology of CKD Regression in Patients under Nephrology Care.肾脏病护理患者慢性肾脏病病情缓解的流行病学
PLoS One. 2015 Oct 13;10(10):e0140138. doi: 10.1371/journal.pone.0140138. eCollection 2015.